MENU

Entera Bio (ENTX) Ownership - Who owns Entera Bio?

Profile

Industry
Pharmaceuticals Major
Address
Minrav Building - Fifth Floor
Phone
+972 25327151
Employees
19
Web
https://www.enterabio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
70.83M
P/E Ratio
N/A
Total Cash
9.06M
Projected Growth
N/A
Total Debt
334K
Revenue
57K
Risk (Beta)
1.80
Dividend Yield
N/A
Total Cash/Share
0.25
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price

Fundamentals

ENTX
Capitalization
70.8M
P/E Ratio
N/A
Risk (Beta)
1.80
Dividend Yield
N/A
Total Cash
9.06M
Total Cash/Share
0.25
Total Debt
334K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
57K
ROE
N/A
Book Value
8.53M
P/B Ratio
8.30
Cash Flow
N/A
Earnings
-0.26
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
7.41
Current Revenue Per Employee
3000.00
Dividends Per Share - Security
N/A
EBITDA
-8.53M
Float
N/A
Float - Current
N/A
Gross Income Margin
15.79
Revenue To Assets
-83.36
Shares Held By Institutions
39.6K
Shares Outstanding - Current
36.3M
Total Liabilities
1.5M
Total Volume MTD
N/A
Value
-1
Gain YTD
225.000
View a ticker or compare two or three
ENTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of flu medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Minrav Building - Fifth Floor
Phone
+972 25327151
Employees
19
Web
https://www.enterabio.com